For research use only. Not for therapeutic Use.
Pericyazine is a typical antipsychotic medication belonging to the phenothiazine class, used primarily in the treatment of schizophrenia and other psychotic disorders. It works by blocking dopamine receptors in the brain, helping to alleviate symptoms such as hallucinations, delusions, and agitation. Additionally, Pericyazine has anxiolytic and sedative properties, making it useful in managing severe anxiety and agitation in certain patients. While effective, it is associated with potential side effects common to antipsychotics, including sedation, extrapyramidal symptoms, and anticholinergic effects. Its use is typically reserved for cases where other antipsychotic treatments are ineffective or not tolerated.
Catalog Number | R049644 |
CAS Number | 2622-26-6 |
Synonyms | 10-[3-(4-Hydroxy-1-piperidinyl)propyl]-10H-phenothiazine-2-carbonitrile; 2-Cyano-10-[3-(4-hydroxypiperidino)propyl]phenothiazine; Aolept; Bayer 1409; FI 6145; Nelactil; Nemactil; Neulactil; Neuleptil; Periciazine; Periciazinum; Properciazine; Proper |
Molecular Formula | C21H23N3OS |
Purity | ≥95% |
Target | Neuronal Signaling |
Storage | Desiccate at -80C |
IUPAC Name | 10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile |
InChI | InChI=1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2 |
InChIKey | LUALIOATIOESLM-UHFFFAOYSA-N |
SMILES | C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N |